Abiraterone Acetate lp (250mg) Unveiling the Efficacy of ABIRASTERON 250 ...

May 21, 2024

Abiraterone Acetate lp (250mg) & ABIRASTERON 250 

Abiraterone Acetate LP (250mg)  ABIRASTERON 250, featuring, a medication widely used in the treatment of advanced prostate cancer. In this article, we'll delve into the therapeutic uses, dosage guidelines, mechanism of action, benefits, potential side effects, and other crucial aspects of ABIRASTERON 250, providing valuable insights into its role in managing this challenging disease.

Understanding ABIRASTERON 250:

1. Therapeutic Indications:


ABIRASTERON 250 is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC), a stage of prostate cancer that no longer responds to hormone therapy and has spread to other parts of the body. As a potent inhibitor of androgen biosynthesis, Abiraterone Acetate LP (250mg) effectively suppresses tumor growth and delays disease progression in patients with mCRPC.

2. Mechanism of Action:

Abiraterone Acetate works by inhibiting the enzyme CYP17A1, which plays a key role in the production of androgens (male sex hormones) such as testosterone. By blocking androgen biosynthesis in the testes, adrenal glands, and tumor tissue, Abiraterone Acetate LP (250mg) reduces the levels of circulating androgens, thereby depriving prostate cancer cells of the fuel they need to grow and survive.

3. Dosage Guidelines:

The recommended dose of ABIRASTERON 250 is 1,000mg (four tablets of 250mg) taken orally once daily in combination with prednisone or prednisolone to minimize the risk of adrenal insufficiency. Patients need to take Abiraterone Acetate on an empty stomach, at least one hour before or two hours after a meal, to maximize absorption and efficacy. Dose adjustments may be necessary based on individual patient factors and tolerability.

4. Benefits of Abiraterone Acetate LP (250mg):

Abiraterone Acetate LP (250mg) offers several benefits for patients with metastatic castration-resistant prostate cancer. Clinical studies have demonstrated its ability to significantly prolong overall survival, delay disease progression, and improve quality of life in this patient population. Additionally, Abiraterone Acetate is well-tolerated, with manageable side effects that can be effectively addressed with supportive care measures.

5. Potential Side Effects:

While ABIRASTERON 250 is generally well-tolerated, it may cause certain side effects in some patients. Common side effects may include fatigue, hypertension, fluid retention, hypokalemia, and liver function abnormalities. Rare but serious side effects such as adrenal insufficiency, cardiac disorders, and allergic reactions may also occur. Patients should be closely monitored for signs of adverse reactions and managed accordingly.

Conclusion:

In conclusion, ABIRASTERON 250 represents a significant advancement in the treatment of metastatic castration-resistant prostate cancer. With its potent inhibitory effects on androgen biosynthesis, Abiraterone Acetate LP (250mg) offers patients a chance to prolong survival, delay disease progression, and improve quality of life. However, it's essential for healthcare providers to closely monitor patients for potential side effects and provide appropriate supportive care. With ABIRASTERON 250, patients can face their prostate cancer journey with hope and confidence. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

 

SHARE WITH